We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed
Dec 24
Have your own idea? Try our Stock Screener
Israeli (TA) Healthcare Sector Analysis
UpdatedJan 13, 2026
DataAggregated Company Financials
Companies39
- 7D9.3%
- 3M11.3%
- 1Y15.8%
- YTD11.8%
Over the last 7 days, the Healthcare industry has risen 9.3%, and SofWave Medical contributed the most with a gain of 25%. During this same period, the InterCure underperformed, falling 6.9%. This means that the industry has gained 16% over the past year. Earnings are forecast to grow by 25% annually.
Sector Valuation and Performance
Has the Israeli Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 13 Jan 2026 | ₪14.5b | ₪8.0b | ₪366.1m | 21.6x | 39.5x | 1.8x |
| Thu, 11 Dec 2025 | ₪12.7b | ₪5.8b | ₪216.1m | 19.4x | 58.7x | 2.2x |
| Sat, 08 Nov 2025 | ₪10.1b | ₪5.9b | ₪201.9m | 19.5x | 50.1x | 1.7x |
| Mon, 06 Oct 2025 | ₪10.1b | ₪5.8b | ₪197.6m | 16.3x | 51.2x | 1.7x |
| Wed, 03 Sep 2025 | ₪10.1b | ₪5.9b | ₪206.5m | 17.3x | 48.8x | 1.7x |
| Fri, 01 Aug 2025 | ₪9.9b | ₪5.9b | ₪110.1m | 17.2x | 89.6x | 1.7x |
| Sun, 29 Jun 2025 | ₪9.6b | ₪5.9b | ₪110.2m | 18.5x | 87.5x | 1.6x |
| Tue, 27 May 2025 | ₪9.5b | ₪5.9b | ₪153.0m | 14x | 62.2x | 1.6x |
| Thu, 24 Apr 2025 | ₪9.1b | ₪5.9b | ₪111.7m | 14.5x | 81.2x | 1.5x |
| Sat, 22 Mar 2025 | ₪9.4b | ₪5.9b | -₪121,191,664.00 | 14x | -77.5x | 1.6x |
| Mon, 17 Feb 2025 | ₪10.2b | ₪5.9b | -₪148,007,444.00 | 14.7x | -68.6x | 1.7x |
| Wed, 15 Jan 2025 | ₪9.9b | ₪5.9b | -₪153,532,077.00 | 15.1x | -64.5x | 1.7x |
| Fri, 13 Dec 2024 | ₪9.3b | ₪5.9b | -₪146,846,168.00 | 16.9x | -63.5x | 1.6x |
| Sun, 10 Nov 2024 | ₪8.8b | ₪5.8b | -₪270,922,468.60 | 14x | -32.6x | 1.5x |
| Tue, 08 Oct 2024 | ₪8.4b | ₪5.8b | -₪279,538,639.90 | 13.8x | -30.1x | 1.4x |
| Thu, 05 Sep 2024 | ₪8.5b | ₪5.8b | -₪315,513,701.90 | 15.3x | -26.9x | 1.5x |
| Sat, 03 Aug 2024 | ₪8.4b | ₪5.9b | -₪476,308,882.80 | 16.2x | -17.5x | 1.4x |
| Mon, 01 Jul 2024 | ₪7.8b | ₪5.9b | -₪467,707,194.50 | 14.8x | -16.7x | 1.3x |
| Wed, 29 May 2024 | ₪8.4b | ₪5.7b | -₪497,214,889.10 | 19x | -17x | 1.5x |
| Fri, 26 Apr 2024 | ₪8.4b | ₪5.7b | -₪524,770,700.50 | 21.3x | -16.1x | 1.5x |
| Sun, 24 Mar 2024 | ₪8.9b | ₪5.6b | -₪461,983,466.50 | 17.8x | -19.2x | 1.6x |
| Tue, 20 Feb 2024 | ₪8.9b | ₪5.6b | -₪487,258,824.70 | 18.6x | -18.3x | 1.6x |
| Thu, 18 Jan 2024 | ₪8.9b | ₪5.7b | -₪598,004,836.00 | 16.3x | -14.9x | 1.6x |
| Sat, 16 Dec 2023 | ₪8.2b | ₪5.7b | -₪574,696,448.00 | 15.8x | -14.4x | 1.4x |
| Mon, 13 Nov 2023 | ₪8.3b | ₪5.6b | -₪594,422,263.00 | 12.8x | -14x | 1.5x |
| Wed, 11 Oct 2023 | ₪8.3b | ₪5.6b | -₪620,738,466.00 | 13x | -13.3x | 1.5x |
| Fri, 08 Sep 2023 | ₪8.7b | ₪5.6b | -₪563,172,393.00 | 13.8x | -15.5x | 1.6x |
| Sun, 06 Aug 2023 | ₪8.3b | ₪5.4b | -₪553,886,211.00 | 12.8x | -14.9x | 1.5x |
| Tue, 04 Jul 2023 | ₪8.2b | ₪5.4b | -₪562,256,043.00 | 10.4x | -14.5x | 1.5x |
| Thu, 01 Jun 2023 | ₪8.0b | ₪5.4b | -₪516,576,500.00 | 10x | -15.4x | 1.5x |
| Sat, 29 Apr 2023 | ₪8.0b | ₪5.3b | -₪468,647,819.00 | 8.6x | -17x | 1.5x |
| Mon, 27 Mar 2023 | ₪8.1b | ₪5.3b | -₪297,392,887.00 | 9.1x | -27.2x | 1.5x |
| Wed, 22 Feb 2023 | ₪8.5b | ₪5.1b | -₪375,371,565.00 | 9.3x | -22.5x | 1.7x |
| Fri, 20 Jan 2023 | ₪9.5b | ₪5.0b | -₪334,001,530.00 | 12.3x | -28.5x | 1.9x |
Price to Earnings Ratio
-28.5x
Current Industry PE
- Investors are optimistic on the Israeli Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 39.5x which is higher than its 3-year average PE of 6.7x.
- The 3-year average PS ratio of 1.6x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 17% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare sector?
| IL Market | 3.03% | |
| Healthcare | 9.29% | |
| Biotech | 19.02% | |
| Medical Equipment | 17.80% | |
| Healthcare Services | 3.91% | |
| Healthtech | 0% | 0 |
| Life Sciences | -0.26% | |
| Pharma | -2.51% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 9.9x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 35% over the next 5 years.
- However this is lower than its past earnings growth rate of 108% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 15% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SOFW SofWave Medical | ₪35.35 | 25.4% +₪255.9m | 118.1% | PE587x | |
| BWAY BrainsWay | ₪38.50 | 20.2% +₪253.0m | 119.6% | PE76.8x | |
| BONS Bonus BioGroup | ₪0.53 | 52.6% +₪214.9m | 244.5% | PE-24.4x | |
| MDTR Mediterranean Towers | ₪15.75 | 7.9% +₪173.7m | 49.1% | PE7.7x | |
| KMDA Kamada | ₪25.40 | 11.6% +₪152.9m | -4.2% | PE22.8x |
